Syphilis seroprevalence and incidence in US blood donors from 2020 to 2022

Abstract

AbstractBackgroundHIV, HBV, and HCV infections for ~60% of the US blood supply are monitored by TTIMS with syphilis added in 2020.Study Design and MethodsData were compiled from October 2020 to September 2022. Syphilis prevalence was estimated for allogeneic and directed donors who were consensus positive (CP) and the subset of those with confirmed‐active infections (AI). Prevalence and incidence were stratified by demographics for two consecutive 1‐year periods, starting October 1, 2020 and for both years combined. Incidence was estimated for repeat donors. Associations between syphilis positivity and other infections were evaluated.ResultsAmong 14.75 million donations, syphilis prevalence was 28.4/100,000 donations and significantly higher during the second year compared to the first year. Overall, syphilis incidence for the two‐year period was 10.8/100,000 person‐years. The adjusted odds of a CP infection were 1.18 (95% CI: 1.11, 1.26) times higher in the second year compared to the first, and for AI, 1.22 (95% CI: 1.10, 1.35) times higher in year 2. Highest rates occurred among males, first‐time, Black, and younger (ages 18–39) donors, and those in the South US Census region. Syphilis CP donors were 64 (95% CI: 46, 89) times more likely to be HIV CP, and AI donors 77 (95% CI: 52, 114) times more likely to be HIV CP than non‐CP donors, when controlling for confounders.Summary/ConclusionsSyphilis prevalence increased over the study period mirroring national trends reported by CDC and is significantly associated with HIV CP.